Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,037 | -16,980 | -88,098 | -68,101 | -46,342 |
| Depreciation Amortization | -1,039 | -385 | 1,850 | 1,859 | 1,458 |
| Other Working Capital | -5,428 | -6,611 | 2,768 | 2,481 | -3,087 |
| Other Operating Activity | 2,993 | 577 | 6,976 | 5,209 | 2,870 |
| Operating Cash Flow | $-38,511 | $-23,399 | $-76,504 | $-58,552 | $-45,101 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,606 | 28,994 | 59,815 | 43,196 | 41,011 |
| PPE Investments | -35 | -3 | -1,953 | -1,769 | -1,034 |
| Investing Cash Flow | $42,571 | $28,991 | $57,862 | $41,427 | $39,977 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 147 | N/A | 503 | 359 | 359 |
| Financing Cash Flow | $147 | $N/A | $503 | $359 | $359 |
| Beginning Cash Position | 10,809 | 10,809 | 28,948 | 28,948 | 28,948 |
| End Cash Position | 15,016 | 16,401 | 10,809 | 12,182 | 24,183 |
| Net Cash Flow | $4,207 | $5,592 | $-18,139 | $-16,766 | $-4,765 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,511 | -23,399 | -76,504 | -58,552 | -45,101 |
| Capital Expenditure | -35 | -3 | -1,953 | -1,769 | -1,034 |
| Free Cash Flow | -38,546 | -23,402 | -78,457 | -60,321 | -46,135 |